# Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness

> **NCT04137432** · PHASE1 · UNKNOWN · sponsor: **University Hospital, Bonn** · enrollment: 60 (estimated)

## Conditions studied

- Loneliness

## Interventions

- **DRUG:** Oxytocin nasal spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04137432
- **Lead sponsor:** University Hospital, Bonn
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-26
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04137432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04137432, "Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04137432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*